{"id":13930,"date":"2026-06-15T20:39:58","date_gmt":"2026-06-15T20:39:58","guid":{"rendered":"https:\/\/medical-article.com\/?p=13930"},"modified":"2026-06-15T20:39:58","modified_gmt":"2026-06-15T20:39:58","slug":"lillys-newly-acquired-drug-shows-promise-as-next-gen-blood-cancer-med","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=13930","title":{"rendered":"Lilly\u2019s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/06\/eli-lilly-myelofibrosis-typeii-jak2-inhibitor-ajax-blood-cancer-hematology-eha-lly\/\"><\/a><\/p>\n<p>Eli Lilly presented encouraging Phase 1 results for AJ1-11095 at the European Hematology Association (EHA) annual meeting in Stockholm. The drug, a type II JAK2 inhibitor in development for myelofibrosis, came from Lilly\u2019s acquisition of biotech startup Ajax Therapeutics. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/06\/eli-lilly-myelofibrosis-typeii-jak2-inhibitor-ajax-blood-cancer-hematology-eha-lly\/\">Lilly\u2019s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Eli Lilly presented encouraging Phase 1 results for AJ1-11095 at the European Hematology Association (EHA) annual meeting in Stockholm. The drug, a type II JAK2 inhibitor in development for myelofibrosis, came from Lilly\u2019s acquisition of biotech startup Ajax Therapeutics. The post Lilly\u2019s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med appeared first on&#8230;<\/p>\n","protected":false},"author":0,"featured_media":13931,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-13930","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/13930"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13930"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/13930\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/13931"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}